These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Quartel A; Turbeville S; Lounsbury D Curr Med Res Opin; 2010 Jun; 26(6):1363-75. PubMed ID: 20377318 [TBL] [Abstract][Full Text] [Related]
5. Treatment for Lambert-Eaton myasthenic syndrome. Keogh M; Sedehizadeh S; Maddison P Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003279. PubMed ID: 21328260 [TBL] [Abstract][Full Text] [Related]
6. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports. Schneider I; Kornhuber ME; Hanisch F J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033 [TBL] [Abstract][Full Text] [Related]
8. Palliative care for a patient with Lambert-Eaton myasthenic syndrome: role of 3,4-diaminopyridine. Chan KY; Chang RS; Lau VW; Chan ML; Lai T Ann Palliat Med; 2016 Oct; 5(4):311-314. PubMed ID: 27506750 [TBL] [Abstract][Full Text] [Related]
9. Treatment in Lambert-Eaton myasthenic syndrome. Maddison P Ann N Y Acad Sci; 2012 Dec; 1275():78-84. PubMed ID: 23278581 [TBL] [Abstract][Full Text] [Related]
10. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer. Schoser B; Eymard B; Datt J; Mantegazza R J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304 [TBL] [Abstract][Full Text] [Related]
12. Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases. Lorenzoni PJ; Scola RH; Kay CS; Parolin SF; Werneck LC Arq Neuropsiquiatr; 2010 Dec; 68(6):849-54. PubMed ID: 21243240 [TBL] [Abstract][Full Text] [Related]
13. 3,4-Diaminopyridine for the treatment of myasthenia gravis with electrophysiological patterns of Lambert-Eaton myasthenic syndrome. Lee MK; Sunwoo IN; Kim SM J Clin Neurosci; 2018 Apr; 50():194-198. PubMed ID: 29402568 [TBL] [Abstract][Full Text] [Related]
14. Amifampridine for the Management of Lambert-Eaton Myasthenic Syndrome: A New Take on an Old Drug. Yoon CH; Owusu-Guha J; Smith A; Buschur P Ann Pharmacother; 2020 Jan; 54(1):56-63. PubMed ID: 31319693 [No Abstract] [Full Text] [Related]
15. Lambert-eaton myasthenic syndrome: diagnosis and treatment. Sanders DB Ann N Y Acad Sci; 2003 Sep; 998():500-8. PubMed ID: 14592920 [TBL] [Abstract][Full Text] [Related]
16. [A retrospective study of the effects of 3,4-diaminopyridine treatment in Lambert-Eaton myasthenic syndrome]. Naganuma R; Yabe I; Takahashi I; Matsushima M; Kano T; Sasaki H Rinsho Shinkeigaku; 2018 Feb; 58(2):83-87. PubMed ID: 29386498 [TBL] [Abstract][Full Text] [Related]
17. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. Wirtz PW; Nijnuis MG; Sotodeh M; Willems LN; Brahim JJ; Putter H; Wintzen AR; Verschuuren JJ; J Neurol; 2003 Jun; 250(6):698-701. PubMed ID: 12796832 [TBL] [Abstract][Full Text] [Related]
18. Available treatment options for the management of Lambert-Eaton myasthenic syndrome. Verschuuren JJ; Wirtz PW; Titulaer MJ; Willems LN; van Gerven J Expert Opin Pharmacother; 2006 Jul; 7(10):1323-36. PubMed ID: 16805718 [TBL] [Abstract][Full Text] [Related]
19. [Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration--with a review of the Japanese literature]. Ohkubo K; Ohishi K; Motomura M; Sakai K; Tsujihata M; Nagataki S No To Shinkei; 1994 Mar; 46(3):285-9. PubMed ID: 8192944 [TBL] [Abstract][Full Text] [Related]